BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, May 4, 2026
Home
»
Authors
»
Aaron Lorenzo
Articles by Aaron Lorenzo
Dynogen Draws $13.3M In Funding With In Vivo Pharmacology Work
Nov. 14, 2002
By
Aaron Lorenzo
Dynogen Draws $13.3M In Funding With In Vivo Pharmacology Work
Nov. 14, 2002
By
Aaron Lorenzo
NeoRx Licenses Technology To IDEC, Considers Others Actions
Nov. 14, 2002
By
Aaron Lorenzo
Baxter Agrees To Acquire Epic In Deal Valued At $50M To $100M
Nov. 12, 2002
By
Aaron Lorenzo
Endo, Durect Enter Potential $57M Collaboration Around Pain System
Nov. 12, 2002
By
Aaron Lorenzo
Endo, Durect Enter Potential $57M Collaboration Around Pain System
Nov. 12, 2002
By
Aaron Lorenzo
Baxter Agrees To Acquire Epic In Deal Valued At $50M To $100M
Nov. 12, 2002
By
Aaron Lorenzo
Seattle Genetics Updates Clinical Pipeline Products
Nov. 8, 2002
By
Aaron Lorenzo
Seattle Genetics Updates Clinical Pipeline Products
Nov. 8, 2002
By
Aaron Lorenzo
Isis Gets Rights To ISIS 14803 Back From Elan Joint Venture
Nov. 7, 2002
By
Aaron Lorenzo
Previous
1
2
…
217
218
219
220
221
222
223
224
225
…
237
238
Next
